IFNL1 and COVID-19: Since IFNλ1–3 are produced early during respiratory viral infections [17,22] and type III IFN subtype levels have been reported to be differently expressed in respiratory and blood samples of severe COVID-19 patients [13,30], we stratified patients into those who required ICU admission and those with mild/moderate disease (Table 1).